Lisa Wilson | IR |
Scott Tarriff | Founder, President, CEO & Director |
Brian Cahill | CFO |
Brandon Folkes | Cantor Fitzgerald & Co. |
Lachlan Hanbury-Brown | William Blair & Company |
David Amsellem | Piper Sandler & Co. |
Good morning, everyone. My name is Gretchen, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' First Quarter 2022 Financial Results. [Operator Instructions]. It is now my pleasure to turn the floor over to Ms.